SCHEMBL4816205

SCHEMBL4816205

O=C(NO)c1ccc(C#CCCNC(=O)c2nc(-c3ccccc3)cs2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
LMNA P02545 3/20 0.50
MAPK1 P28482 1/20 0.50
MASP2 O00187 1/20 0.44
F2 P00734 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
USP30 Q70CQ3 3/20 0.44
KDM4E B2RXH2 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HPGD P15428 1/20 0.43
SCD O00767 1/20 0.42
ALDH1A1 P00352 3/20 0.42
GAA P10253 3/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811116 0.90 MAOB (0.48) MAPTLMNAMAPK1MASP2F2
SCHEMBL4821586 0.89 ALDH1A1 (0.46) MAPTLMNAMAPK1MASP2F2
SCHEMBL4256684 0.82 MASP2 (0.46) MAPTLMNAMAPK1MASP2F2
SCHEMBL445187 0.81 MAPT (0.52) MAPTLMNAMAPK1NR1H4KDM4E
SCHEMBL5970393 0.81 MASP2 (0.50) MAPTLMNAMAPK1MASP2F2
SCHEMBL4820706 0.80 MAPT (0.44) MAPTLMNAMAPK1MASP2F2
SCHEMBL443783 0.80 NPC1 (0.52) MAPTLMNAMAPK1NR1H4KDM4E
SCHEMBL445221 0.79 MAPT (0.50) MAPTLMNAMAPK1NR1H4KDM4E
SCHEMBL4815776 0.79 MAPT (0.45) MAPTLMNAMAPK1MASP2F2
SCHEMBL5971496 0.77 MASP2 (0.48) MAPTLMNAMASP2F2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2008-06-12 US claimed
US-7368572-B2 Acetylene derivatives as inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2008-05-06 US claimed
EP-1656348-B1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARM INC (US) 2007-02-07 EP claimed
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2005-06-16 US claimed
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2008-06-12 US disclosed
US-7368572-B2 Acetylene derivatives as inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2008-05-06 US disclosed
EP-1656348-B1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARM INC (US) 2007-02-07 EP disclosed
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC10, HDAC2 MAPT 2799/4885LMNA 1342/4885MAPK1 3438/4885
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase HDAC1, HDAC10, HDAC2 MAPT 2799/4885LMNA 1342/4885MAPK1 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.